International Biotechnology (LON:IBT) Stock Price Crosses Above 200-Day Moving Average – Should You Sell?

Shares of International Biotechnology (LON:IBT) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 934.40 and traded as high as GBX 988. International Biotechnology shares last traded at GBX 970, with a volume of 42,238 shares traded.

International Biotechnology Stock Down 0.6%

The company has a debt-to-equity ratio of 9.43, a current ratio of 0.11 and a quick ratio of 0.32. The firm’s 50-day moving average is GBX 940.21 and its 200 day moving average is GBX 934.40. The stock has a market cap of £308.73 million, a price-to-earnings ratio of -294.83 and a beta of 0.32.

International Biotechnology (LON:IBT) last issued its quarterly earnings results on Tuesday, May 12th. The company reported GBX (4.83) EPS for the quarter. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%.The company had revenue of GBX 24 million for the quarter. Sell-side analysts anticipate that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.